European Commission Approves Krazati as Targeted Therapy for Advanced NSCLC with KRASG12C Mutation
On January 10, 2024, the European Commission granted its approval to Krazati (adagrasib) as a targeted therapy for individuals suffering ...
On January 10, 2024, the European Commission granted its approval to Krazati (adagrasib) as a targeted therapy for individuals suffering ...
August 14, 2023 - SG Americas Securities LLC Makes a Bold Move by Acquiring New Stake in Mirati Therapeutics, Inc. ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.